{"id":1599,"date":"2023-02-09T07:00:00","date_gmt":"2023-02-09T06:00:00","guid":{"rendered":"https:\/\/d3glparxwv1yl3.cloudfront.net\/annualreport\/press-releases\/ipsen-presents-strong-full-year-2022-results-and-guidance-for-2023\/"},"modified":"2023-05-23T14:11:17","modified_gmt":"2023-05-23T14:11:17","slug":"ipsen-presents-strong-full-year-2022-results-and-guidance-for-2023","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/annualreport\/press-releases\/ipsen-presents-strong-full-year-2022-results-and-guidance-for-2023\/","title":{"rendered":"Ipsen presents strong full-year 2022 results and guidance for 2023"},"content":{"rendered":"
Paris (France), 9 February 2023<\/strong>
Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents today its financial results for the year and the fourth quarter of 2022.<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[],"tags":[],"class_list":["post-1599","press_release","type-press_release","status-publish","hentry","entry"],"acf":[],"yoast_head":"\n